Analysts expect soaring profits and investors are hoping for big guidance. Can the electric-car company deliver?
These two pharma heavyweights are among the many players racing to get a COVID-19 vaccine approved.
It gives the video game retailer a financial incentive to remain in the digital gaming ecosystem.
Apple shares have doubled in the last year. Can the tech giant keep delivering market-beating returns from here?
Health Canada will determine BNT162b2's suitability for approval as clinical trial data comes in.
Forget politics and a pandemic. The outlook for these stocks keeps getting better, and analysts can't keep up.
The enterprise messaging platform is adding more remote work features.
These high-yield dividend stocks could see activity as they announce earnings this month.
Here are the answers to your top questions about where things stand with the development of COVID-19 vaccines.
Just follow these three simple steps.